4

Defer permanently sporadic and familial CJD and first-degree relatives Defer permanently if history of treatment with pituitary-derived human growth hormone, human gonadotrophin, dura mater graft, corneal transplantation, neurosurgery Also refer to Section 7.7.1 58, 65, 86–87 Crohn’s disease Refer to Section 5.4 55 Dementia Defer permanently Also refer to Section 5.8.3 58–59 Dengue virus Refer to Section 7.3.5 77 Dental treatment Accept 24 hours after simple procedures and 7 days after extraction or endodontic procedures 67 Depression Accept if feeling well 61–62 Dermatomyositis Defer permanently 57, 60–61 Diabetes Accept diabetes mellitus controlled by diet or oral medication provided no history of orthostatic hypotension and no evidence of infection, neuropathy or vascular disease Defer permanently if requires insulin treatment or has complications with multi-organ involvement 56 Diagnostic procedures Defer following minor diagnostic procedure including rigid endoscopy until normal activity resumed Defer for 12 months following invasive diagnostic procedure using flexible endoscopy 67 9 Diarrhoea Accept 14 days after full recovery and completion of therapy, including antibiotics Accept chronic diarrhoea due to irritable bowel syndrome without debility; otherwise defer Defer for 28 days if symptoms suggestive of Yersinia enterocolitica 41, 82, 83, 84–85 Diverticular disease Accept if well 55 Drug use Injecting drug use: Defer permanently individuals with a history of injecting drug use Also refer to Section 7.9.2 88–89 Non-injected drugs and alcohol use: Accept if no signs of intoxication Defer if displaying signs and symptoms of intoxication 89 Eczema Refer to Section 5.11 57, 61 Epilepsy Accept if off medication and seizure-free for 3 years 58–59 Epstein-Barr virus Defer until 28 days after full recovery Also refer to Section 7.3.4 76 Erythrocytosis Accept secondary erythrocytosis if diagnosis of polycythaemia rubra vera excluded 51 Essential thrombocythaemia Defer permanently 60 Fever (non-specific) Defer until 14 days after full recovery Also refer to Section 4.3 41, 42, 72, 79–81, 82, 83, 84 Fracture Accept when plaster removed and mobile 60 Frequency of donation For whole blood, minimum of 12 weeks for males, 16 weeks for females Also refer to Section 4.6.2 44–46 Gallstones Accept if well 55 Gastro-oesophageal reflux Accept if mild 55 Gonorrhoea Defer for 12 months following completion of treatment and assess for high-risk behaviour Also refer to Section 7.5.1 74, 83–84 G6PD deficiency Accept if no history of haemolysis Defer permanently if history of haemolysis 50–51 10 Haemochromatosis Accept provided meets other criteria 45, 52 Haemoglobin level for blood donation Not less than 12.0 g/dl for females Not less than 13.0 g/dl for males Also refer to Sections 4.6 and 4.10 43–44, 48 Haemoglobinopathies Defer permanently thalassaemia major or sickle cell disease Also refer to Section 5.1.2 50 Haemophilia Refer to Section 5.1.7 52 Hepatitis A, hepatitis E and hepatitis of unknown origin Defer for 12 months following full recovery Also refer to Section 7.3.1 73–74 Hepatitis B Refer to Section 7.3.1 72–73, 87–90 Hepatitis C Refer to Section 7.3.1 73, 87–90 Herpes Accept cold sores and genital herpes provided no active lesions Defer symptomatic individuals for at least 28 days following full recovery Defer permanently individuals with HHV8 infection and current or former sexual contacts Also refer to Section 7.3.4 76 Hiatus hernia Accept mild cases, provided well 55 HIV/AIDS Refer to Section 7.3.2 74–75, 83, 87–90 HTLV Refer to Section 7.3.3 75 Hypertension Accept stable uncomplicated hypertension controlled by medication Defer if recently started or changed antihypertensive medication until 28 days after blood pressure stabilized Defer permanently if hypertensive heart or renal disease 53–54 Hypogammaglobulinaemia Defer permanently 57 Immunization Refer to Section 6.1 63–64 Immunological diseases Refer to Section 5.6 57 Infections (acute bacterial) Accept 14 days after full recovery and completion of antibiotic treatment Defer for 28 days following full recovery and completion of treatment if symptoms suggestive of infection with salmonella, campylobacter, streptococcus or staphylococcus 41, 85 11 Influenza Accept asymptomatic individuals with no close contact with those having active infection Defer for 14 days after full recovery and cessation of any therapy Defer for 48 hours after vaccination Also refer to Section 7.3.7 78 Inoculation injury Defer for 12 months following exposure 73 Iron deficiency Refer to Section 5.1.1 43–46, 49 Irritable bowel syndrome Accept, if without debility 55 Leishmaniasis Refer to Section 7.4.4 82–83 Leukaemia Defer permanently 59–60 Lyme disease Defer for 28 days following full recovery and

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25